{"ticker": {"uuid": "f976caa2-35a9-4e7a-ac13-e3c446f9d832", "symbol": "ACL", "name": "Australian Clinical Labs Limited", "exchange": "ASX", "country": "AU", "sector": "Healthcare", "industry": "Diagnostics & Research"}, "articles": [{"title": "Why Australian Clinical Labs Is Back on the Small-Cap Radar", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQbXRGTi1VRFNwQS1NTzZfeDlBalJucXdLbmptWnFOd3IxRFAwcWpYTE9URVl1Vkoxc0M1UUVSM3JTSzhTM3ByZTBmTVNaM21EX2pYeG94M1g4QmdWT1NSRERzMGlyUzV0MlQxUk04MjN0dFlCTUpTY1RHbW1mWm5IYXZ2N1gwdW5NMlliRFVMSVV1RkJJd1B0Q3dRUHY2UUk2bEE?oc=5", "source_name": "Kalkine Media", "published_at": "2026-06-19T01:54:00+00:00", "published_display": "19 Jun 2026 01:54", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ASX Penny Stock Highlights: Australian Clinical Labs Among 3 Noteworthy Picks", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-18T02:57:27+00:00", "published_display": "18 Jun 2026 02:57", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Australian Clinical Labs Slips After Appointing Former Healthscope Boss as CEO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQZmc1V0RhVkloVkIySHJ0amw0Y3ZxTmpqNWpiQm41SWw5NFc5T2ZROG1zSkd4YWd3N3Nra01feWZ1cVBmUU0xY1ZteGxLakNDRl9uT3B0eXR2cTVudjJReEkwNnRaN05UbGJBRTBWeExkdjVpQ2Z6bk1jT1dxQzI0SFpIVWlWZmlLaFpiQnA5Y25sWlFyajVYc1BOQjhUYjFaN1lRR1k0RGdsbHJiRWVmYURkVmhJaUQ2?oc=5", "source_name": "Kalkine", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Greg Horan appointed CEO of Australian Clinical Labs", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxQVF9SQktIYzhzODBmanRrU1kyUTluWFhUQzdOazJhUDBKRTBfRXpmMzF0NnM0VnNudEdXb1F4WTV4U09VNnlCb3hYQS1PbFVUdWVPLTBKMVZlMTY2Y184NWJlOEl3a0lwWE1WT2NxSTF6RFJFQWh0eGo4bGhRTTNhcXRHUG5jT2RqNVZ0d0hQakdZQQ?oc=5", "source_name": "grafa.com", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Australian Clinical Labs (ASX:ACL) Shares Draw Attention After Latest Appendix 3C Filing", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPdWg5RS1zenRXdFZGUy12aTd1UnZ1d2MxeUhmT1FiNUZORjJ5Qk5tekJSQVNDNVQ2eXpvWVB6Sm8yYXRTc2MxaXVLb1JCU3NKbnd3MmlCX0huWkM2YThkTGk5cEZTWlBXMDZSNXA3N1lJYXZzZjhCeWpya3dnUXNjcXVaZnNwS3A2NU0ycHZxUU8weVNSR0txQmVZcnpSb2ZsdmYySVpIWDN2MjVhN0NISkNnSTZQYTJZYy1tZHV5NWJwUQ?oc=5", "source_name": "Kalkine", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Australian Clinical Labs (ASX:ACL) Valuation After Softer Half Year Earnings And Interim Dividend", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-18T08:00:00+00:00", "published_display": "18 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Australian Clinical Labs (ASX:ACL) Balancing Dividends And Leadership Change Or Stretching Its Strategy?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxONi1zNWhXeGFad2s0ZUFpUDc5Y2ZTSGJ2YnBDZHpwWWtjSHJoZlZSZjNiN0h6bnBuMk95LVJLRGdPZ1llOVlvSTJXTXZES0NuemlhVlo4dEtCYU9GWlNMWkpJbkV3amZMZFplVEFLaC1BTGRTRUdISzlaR29tLVcxcTltb0U?oc=5", "source_name": "Market source", "published_at": "2026-02-18T08:00:00+00:00", "published_display": "18 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Australian Clinical Labs H1 2026 Margin Compression Challenges Bullish Efficiency Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-17T08:00:00+00:00", "published_display": "17 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Australian Clinical Labs shares hit record low as CEO to exit", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOWHc2cUlvdFhENm1rb2Nyb2NPd2tPZWxrT2txdkl1bUNGTGFHSXNWbFpGMnJGTFNENGQ0ZjlvWWxLT3RXVnVRRUVJRFFKeGZ6bEtEUUc0YzU3Nk5lOHRRYy1CMkI4MzZZM1Vacmx2ZU1OdVRHQkxiU3Y4U0ZHbjNtZnE5NlA4NDZySHR5VGRPMHllT3lHOTJSOE1ObklUUQ?oc=5", "source_name": "The Motley Fool Australia", "published_at": "2026-02-16T08:00:00+00:00", "published_display": "16 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Audinate, Australian Clinical Labs, Coronado, and Treasury Wine shares are sinking today", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNYXVDRE5fOUJUdDFWMlJBdThkc2pMbnUzN29QeGFnSzNtaXJFcUtBeGhIcnpnNDJYOXlielpDbzY3ZWM0SDRNdWk4WnEyQjdmWVN6V0FaRWgzQ3cySmpKTWpJeUJXOUtDZ0ZFNkdCdEJLa3VJZ3lINEs4TEpjWTBhbzU2UW5sWWNsT3p1WkV6dXZmSU5pMDFCelpBVHlrYTcxNmlRWDdlY005SEp6aHVMN3ZyVnJrM1BEdUEtaHhVTHRCd2s?oc=5", "source_name": "The Motley Fool Australia", "published_at": "2026-02-16T08:00:00+00:00", "published_display": "16 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Australian Clinical Labs (ASX:ACL) The Statutory Hit Spooked Investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMiY0FVX3lxTE9xbUJzeDlJOG56eGpXMkE4UE9qQjJKZW5EYjhTaV83MFc1bDZjZW9FeGVLaEI0NkRIeGNXeFRkZzh3TFRyQ2U2YUF6eFZjWjlUeURiV01MeE1qeW1aYVltbDhUVQ?oc=5", "source_name": "Stocks Down Under", "published_at": "2026-02-16T08:00:00+00:00", "published_display": "16 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Australian Clinical Labs, Karoon Energy, MA Financial, and Silex shares are roaring higher today", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxQeDBkOWhQYVhFWnE4WVZ6OVIyenhlckZ1Y1RaWkdYY0RtZTJPZVpxWE42YmJjSW1CT0kyZkJHdTE5WHlIUFBabmlOXzhxN2F4MkhTMFVvV0FqdHJGMEJVdDZnRHFHOUo2eVF1OGFHWm94Y2JqYm56bTZtY0dRNXRETERWaGVfUldGWEpGWUVUTDlNdE9MVnk2MVBlTGtEYTFTWE5rNHFSVFlOV3pTX3Q5Q3pMQkNhalpBdnVLNDhNSWRqdGZrMXVsSGpDUV8yUQ?oc=5", "source_name": "The Motley Fool Australia", "published_at": "2025-10-23T07:00:00+00:00", "published_display": "23 Oct 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analyst Estimates: Here's What Brokers Think Of Australian Clinical Labs Limited (ASX:ACL) After Its Full-Year Report", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQYjB3QXJfYUdwOWVfY2Z0bGJxbVl5aGx3TjV5RXJSdlR3WWU3UDlzVWs0MFhsQ1lkc3BHZWczbjByeFl4U0hPV3BjSFNIMDdKbVRUMjlaOHlvMlJFTlBXNk1NQ1l0MmRLN3dFbDdIWnczbnFXTUJZUDZreWlyRUVHTzNRaXVDZGZ2Z3k0?oc=5", "source_name": "Market source", "published_at": "2025-08-28T07:00:00+00:00", "published_display": "28 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Australian Clinical Labs Limited (ASX:ACL) Potentially Undervalued?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxNTm9jQ204VWlJZmRsOG1LSjJNcldjUWdBcEJkekZ0TWhqVjZxVTNTS3V6cmpqTzZ2aXVlaHFVVUYtUDhpSXMyOEg4SmozQ1VPU2d3cUJjUU52R1NsUlFPVzdmRk1jbEQzaHFkLV9jaDVuTjVraERveng5ajM5OHZhRnlhZ3BGMVd1QVE?oc=5", "source_name": "Market source", "published_at": "2025-08-27T07:00:00+00:00", "published_display": "27 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "With 53% ownership of the shares, Australian Clinical Labs Limited (ASX:ACL) is heavily dominated by institutional owners", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxOa0NaaG1fQ2tIYlFKck96LXpteHcyVzlGcU9acGlmaGV2ZVBQME9jcmctZ1BIQUZ1WEprWDFDMHBqNmhDaDlSMXN2ODlXR2RkR2tMeUw5b21vOGQxVW1SSVZGTFlzLUV1MHJMTldKMC03blpqekloMG5weFA3OExva0d1XzR0cFdYZWloc3NB?oc=5", "source_name": "Market source", "published_at": "2022-09-06T07:00:00+00:00", "published_display": "06 Sep 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Why Australian Clinical Labs Is Back on the Small-Cap Radar", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQbXRGTi1VRFNwQS1NTzZfeDlBalJucXdLbmptWnFOd3IxRFAwcWpYTE9URVl1Vkoxc0M1UUVSM3JTSzhTM3ByZTBmTVNaM21EX2pYeG94M1g4QmdWT1NSRERzMGlyUzV0MlQxUk04MjN0dFlCTUpTY1RHbW1mWm5IYXZ2N1gwdW5NMlliRFVMSVV1RkJJd1B0Q3dRUHY2UUk2bEE?oc=5", "source_name": "Kalkine Media", "published_at": "2026-06-19T01:54:00+00:00", "published_display": "19 Jun 2026 01:54", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ASX Penny Stock Highlights: Australian Clinical Labs Among 3 Noteworthy Picks", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-18T02:57:27+00:00", "published_display": "18 Jun 2026 02:57", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Australian Clinical Labs Slips After Appointing Former Healthscope Boss as CEO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQZmc1V0RhVkloVkIySHJ0amw0Y3ZxTmpqNWpiQm41SWw5NFc5T2ZROG1zSkd4YWd3N3Nra01feWZ1cVBmUU0xY1ZteGxLakNDRl9uT3B0eXR2cTVudjJReEkwNnRaN05UbGJBRTBWeExkdjVpQ2Z6bk1jT1dxQzI0SFpIVWlWZmlLaFpiQnA5Y25sWlFyajVYc1BOQjhUYjFaN1lRR1k0RGdsbHJiRWVmYURkVmhJaUQ2?oc=5", "source_name": "Kalkine", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Greg Horan appointed CEO of Australian Clinical Labs", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxQVF9SQktIYzhzODBmanRrU1kyUTluWFhUQzdOazJhUDBKRTBfRXpmMzF0NnM0VnNudEdXb1F4WTV4U09VNnlCb3hYQS1PbFVUdWVPLTBKMVZlMTY2Y184NWJlOEl3a0lwWE1WT2NxSTF6RFJFQWh0eGo4bGhRTTNhcXRHUG5jT2RqNVZ0d0hQakdZQQ?oc=5", "source_name": "grafa.com", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Australian Clinical Labs (ASX:ACL) Shares Draw Attention After Latest Appendix 3C Filing", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPdWg5RS1zenRXdFZGUy12aTd1UnZ1d2MxeUhmT1FiNUZORjJ5Qk5tekJSQVNDNVQ2eXpvWVB6Sm8yYXRTc2MxaXVLb1JCU3NKbnd3MmlCX0huWkM2YThkTGk5cEZTWlBXMDZSNXA3N1lJYXZzZjhCeWpya3dnUXNjcXVaZnNwS3A2NU0ycHZxUU8weVNSR0txQmVZcnpSb2ZsdmYySVpIWDN2MjVhN0NISkNnSTZQYTJZYy1tZHV5NWJwUQ?oc=5", "source_name": "Kalkine", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Australian Clinical Labs (ASX:ACL) Valuation After Softer Half Year Earnings And Interim Dividend", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxObFAweURBR0FBOEtxMktxeHpTRXR3TWdCZGZzRE1FNldaT3FGVS1sYTJtNjR1M1JSNjFNMWJPWjVHUjFXdWtaSUNYZ2R6Zmlzanh1QjVoaVJNZm9sSWhXLXlHLXNGcmNEVDNYZFRnbjl2eGZMT0FoNnVleVlQVVpNYnRsUllqN3lTOXY2Vng2X2dUZFRFR0lsTkpKLXR2MjlTaWpJZHBaejBUVllScHhabUdfQ2lNT25uT3BsdGxydjZQbHlYZ2JSN2ItV19xdzd1WHJXczhXRjI0dVlGYUlXYmh30gHnAUFVX3lxTE9MX0JBSE5jMnpZY251SkFKQ0JoYW9fQ2o5bDZoRnk5V0tEb3AxLVk0ZEc0dkREMUZ0RVZnZ0lIZUlMRE52YnRLRzFrRDhaVXJibU9GQmQ1UzA1eW9pTjhNc2hwUGZsdjlhbDV6NW5KempuLVNnU1RfcnpSMUdxM2ctTEVmbnJXaEJvRmg2S2J1My1lWGVjNk93VktwVGdsSnBoaldpSkdsMVJGcmswODk4a1dFSzVjeEpQS09MRlNJdGhBdGlaR1UzX2VqalB6OW1BT1RNWWdrTXBXOGlKd0JfckVTTXFpMA?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-18T08:00:00+00:00", "published_display": "18 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Australian Clinical Labs (ASX:ACL) Balancing Dividends And Leadership Change Or Stretching Its Strategy?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxONi1zNWhXeGFad2s0ZUFpUDc5Y2ZTSGJ2YnBDZHpwWWtjSHJoZlZSZjNiN0h6bnBuMk95LVJLRGdPZ1llOVlvSTJXTXZES0NuemlhVlo4dEtCYU9GWlNMWkpJbkV3amZMZFplVEFLaC1BTGRTRUdISzlaR29tLVcxcTltb0U?oc=5", "source_name": "Market source", "published_at": "2026-02-18T08:00:00+00:00", "published_display": "18 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Australian Clinical Labs H1 2026 Margin Compression Challenges Bullish Efficiency Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-17T08:00:00+00:00", "published_display": "17 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Australian Clinical Labs shares hit record low as CEO to exit", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOWHc2cUlvdFhENm1rb2Nyb2NPd2tPZWxrT2txdkl1bUNGTGFHSXNWbFpGMnJGTFNENGQ0ZjlvWWxLT3RXVnVRRUVJRFFKeGZ6bEtEUUc0YzU3Nk5lOHRRYy1CMkI4MzZZM1Vacmx2ZU1OdVRHQkxiU3Y4U0ZHbjNtZnE5NlA4NDZySHR5VGRPMHllT3lHOTJSOE1ObklUUQ?oc=5", "source_name": "The Motley Fool Australia", "published_at": "2026-02-16T08:00:00+00:00", "published_display": "16 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Audinate, Australian Clinical Labs, Coronado, and Treasury Wine shares are sinking today", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNYXVDRE5fOUJUdDFWMlJBdThkc2pMbnUzN29QeGFnSzNtaXJFcUtBeGhIcnpnNDJYOXlielpDbzY3ZWM0SDRNdWk4WnEyQjdmWVN6V0FaRWgzQ3cySmpKTWpJeUJXOUtDZ0ZFNkdCdEJLa3VJZ3lINEs4TEpjWTBhbzU2UW5sWWNsT3p1WkV6dXZmSU5pMDFCelpBVHlrYTcxNmlRWDdlY005SEp6aHVMN3ZyVnJrM1BEdUEtaHhVTHRCd2s?oc=5", "source_name": "The Motley Fool Australia", "published_at": "2026-02-16T08:00:00+00:00", "published_display": "16 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Australian Clinical Labs (ASX:ACL) The Statutory Hit Spooked Investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMiY0FVX3lxTE9xbUJzeDlJOG56eGpXMkE4UE9qQjJKZW5EYjhTaV83MFc1bDZjZW9FeGVLaEI0NkRIeGNXeFRkZzh3TFRyQ2U2YUF6eFZjWjlUeURiV01MeE1qeW1aYVltbDhUVQ?oc=5", "source_name": "Stocks Down Under", "published_at": "2026-02-16T08:00:00+00:00", "published_display": "16 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Australian Clinical Labs, Karoon Energy, MA Financial, and Silex shares are roaring higher today", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxQeDBkOWhQYVhFWnE4WVZ6OVIyenhlckZ1Y1RaWkdYY0RtZTJPZVpxWE42YmJjSW1CT0kyZkJHdTE5WHlIUFBabmlOXzhxN2F4MkhTMFVvV0FqdHJGMEJVdDZnRHFHOUo2eVF1OGFHWm94Y2JqYm56bTZtY0dRNXRETERWaGVfUldGWEpGWUVUTDlNdE9MVnk2MVBlTGtEYTFTWE5rNHFSVFlOV3pTX3Q5Q3pMQkNhalpBdnVLNDhNSWRqdGZrMXVsSGpDUV8yUQ?oc=5", "source_name": "The Motley Fool Australia", "published_at": "2025-10-23T07:00:00+00:00", "published_display": "23 Oct 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analyst Estimates: Here's What Brokers Think Of Australian Clinical Labs Limited (ASX:ACL) After Its Full-Year Report", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQYjB3QXJfYUdwOWVfY2Z0bGJxbVl5aGx3TjV5RXJSdlR3WWU3UDlzVWs0MFhsQ1lkc3BHZWczbjByeFl4U0hPV3BjSFNIMDdKbVRUMjlaOHlvMlJFTlBXNk1NQ1l0MmRLN3dFbDdIWnczbnFXTUJZUDZreWlyRUVHTzNRaXVDZGZ2Z3k0?oc=5", "source_name": "Market source", "published_at": "2025-08-28T07:00:00+00:00", "published_display": "28 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Australian Clinical Labs Limited (ASX:ACL) Potentially Undervalued?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxNTm9jQ204VWlJZmRsOG1LSjJNcldjUWdBcEJkekZ0TWhqVjZxVTNTS3V6cmpqTzZ2aXVlaHFVVUYtUDhpSXMyOEg4SmozQ1VPU2d3cUJjUU52R1NsUlFPVzdmRk1jbEQzaHFkLV9jaDVuTjVraERveng5ajM5OHZhRnlhZ3BGMVd1QVE?oc=5", "source_name": "Market source", "published_at": "2025-08-27T07:00:00+00:00", "published_display": "27 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "With 53% ownership of the shares, Australian Clinical Labs Limited (ASX:ACL) is heavily dominated by institutional owners", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxOa0NaaG1fQ2tIYlFKck96LXpteHcyVzlGcU9acGlmaGV2ZVBQME9jcmctZ1BIQUZ1WEprWDFDMHBqNmhDaDlSMXN2ODlXR2RkR2tMeUw5b21vOGQxVW1SSVZGTFlzLUV1MHJMTldKMC03blpqekloMG5weFA3OExva0d1XzR0cFdYZWloc3NB?oc=5", "source_name": "Market source", "published_at": "2022-09-06T07:00:00+00:00", "published_display": "06 Sep 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 86, "total_relevant": 15, "sentiment_summary": {"positive": 3, "negative": 0, "neutral": 12, "score": 53, "total": 15, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 88, "events": [{"event": "general", "label": "Market update", "weight": 6.6, "count": 12}, {"event": "earnings", "label": "Earnings", "weight": 1.1, "count": 2}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 3, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 2.19, "latest_week": "2026-06-19", "one_week_move": 1.4, "four_week_move": 11.2, "twelve_week_move": 8.4, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.406877, "market_dynamics_buy_signal": false, "relative_strength": -9.907316, "fair_value_gap": -16.9, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 47.4206, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+1.4% over one week, +11.2% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 64, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 4}, {"label": "simplywall.st", "count": 3}, {"label": "The Motley Fool Australia", "count": 3}, {"label": "Kalkine", "count": 2}, {"label": "Kalkine Media", "count": 1}, {"label": "grafa.com", "count": 1}, {"label": "Stocks Down Under", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 15}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 12}, {"label": "Earnings", "count": 2}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "88/100 classification confidence."}, {"label": "Company focus", "value": "15", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+1.4% over one week, +11.2% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Why Australian Clinical Labs Is Back on the Small-Cap Radar"}], "updated_at": "2026-06-22T11:05:18.302487+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}